Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 8, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-02-26
DOI
10.1126/sciadv.abf9096
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin
- (2019) Giovanni Mario Pes et al. ACTA ONCOLOGICA
- Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
- (2019) Hyunkoo Kang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic significance of G6PD expression and localization in lung adenocarcinoma
- (2018) Ryo Nagashio et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
- (2018) Philipp Nuhn et al. EUROPEAN UROLOGY
- Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System
- (2018) Weipeng Hong et al. Frontiers in Pharmacology
- Baseline low serum dehydroepiandrosterone sulfate can predict poor responsiveness to hormone therapy in patients with hormone-naïve prostate cancer with skeletal metastases
- (2017) Akihiro Yano et al. INTERNATIONAL JOURNAL OF UROLOGY
- Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer
- (2017) H-Q Ju et al. ONCOGENE
- G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3
- (2017) Qiao Zhang et al. Oncotarget
- Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma
- (2017) Qiao Zhang et al. Journal of Cancer
- Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis
- (2017) Evaristus Chibunna Mbanefo et al. Scientific Reports
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
- (2016) Edoardo Gaude et al. Nature Communications
- Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension
- (2015) Sukrutha Chettimada et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells
- (2015) XIAOLIN WANG et al. Molecular Medicine Reports
- Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer
- (2015) Yasuhide Miyoshi et al. PROSTATE
- Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma
- (2015) Haihong Pu et al. World Journal of Surgical Oncology
- A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
- (2014) Nelma Pértega-Gomes et al. BMC CANCER
- Regulation of the pentose phosphate pathway by an androgen receptor–mTOR-mediated mechanism and its role in prostate cancer cell growth
- (2014) E Tsouko et al. Oncogenesis
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model
- (2013) Tao Hu et al. BMC CANCER
- Serum Androgens As Prognostic Biomarkers in Castration-Resistant Prostate Cancer: Results From an Analysis of a Randomized Phase III Trial
- (2013) Charles J. Ryan et al. JOURNAL OF CLINICAL ONCOLOGY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay
- (2012) T. Fiaschi et al. CANCER RESEARCH
- The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
- (2012) Chiara Riganti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 and S9346)
- (2012) Catherine M. Tangen et al. JOURNAL OF UROLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- NCBI GEO: archive for functional genomics data sets—update
- (2012) Tanya Barrett et al. NUCLEIC ACIDS RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Overexpression of G6PD is associated with poor clinical outcome in gastric cancer
- (2011) Jixu Wang et al. TUMOR BIOLOGY
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol
- (2010) Elin Thysell et al. PLoS One
- Metabolomic Profiling of Anionic Metabolites by Capillary Electrophoresis Mass Spectrometry
- (2009) Tomoyoshi Soga et al. ANALYTICAL CHEMISTRY
- Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway
- (2009) Hong-Zhi Sun et al. JOURNAL OF ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started